Abbott Laboratories is a well-known pharmaceutical company that manufactures and sells generic pharmaceuticals, nutritionals, diagnostic products, and medical devices. The company is known worldwide for many renowned brands like Similac infant formula, the Ensure line of nutritional supplements, its FreeStyle diabetes care line, and its Xience drug-eluting stents. In 2017, the company acquired another renowned medical device manufacturer, St. Jude Medical.
In recent years, the company's strong financial performance, coupled with a diversified customer base, geographical diversification, and robust manufacturing capabilities, has ensured that its business keeps growing. The company has focused on building country-specific portfolios, especially developing its brands to meet the needs of patients in many emerging markets. Abbott has over 400 healthcare and pharmaceutical development projects that are active in many emerging markets.
The company's focus on molecular diagnostics has stood it in good stead during the COVID-19 pandemic. The company got emergency use authorization from the FDA to distribute nine COVID-19 rapid antigen tests. The company's BinaxNOW COVID-19 Ag Card test is one of the fastest available molecular tests for detecting the novel coronavirus.
The publisher presents Analysis of Abbott Laboratories. A complete and comprehensive analysis of Abbott Laboratories includes an overview of the industry the company operates in and the impact of the COVID-19 pandemic on the pharmaceutical industry.
Company analysis includes a history of Abbott Laboratories, a business segment analysis of the segments Abbott Laboratories operates through, a look at the organization structure of the company, its product pipeline, investment analysis, a geographical operating segments analysis, and how Abbott Laboratories has been working at the forefront during the COVID-19 pandemic are all analyzed comprehensively in this report.
The major competitors of Abbott Laboratories, namely Dr. Reddy's Laboratories Limited, Johnson & Johnson, and Novartis AG, are analyzed through a company profile, in-depth business segment analysis, a financial analysis, and SWOT analysis. An economic analysis of Abbott Laboratories is also presented through ratio analysis, profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of Abbott Laboratories completes this in-depth company analysis.
In recent years, the company's strong financial performance, coupled with a diversified customer base, geographical diversification, and robust manufacturing capabilities, has ensured that its business keeps growing. The company has focused on building country-specific portfolios, especially developing its brands to meet the needs of patients in many emerging markets. Abbott has over 400 healthcare and pharmaceutical development projects that are active in many emerging markets.
The company's focus on molecular diagnostics has stood it in good stead during the COVID-19 pandemic. The company got emergency use authorization from the FDA to distribute nine COVID-19 rapid antigen tests. The company's BinaxNOW COVID-19 Ag Card test is one of the fastest available molecular tests for detecting the novel coronavirus.
The publisher presents Analysis of Abbott Laboratories. A complete and comprehensive analysis of Abbott Laboratories includes an overview of the industry the company operates in and the impact of the COVID-19 pandemic on the pharmaceutical industry.
Company analysis includes a history of Abbott Laboratories, a business segment analysis of the segments Abbott Laboratories operates through, a look at the organization structure of the company, its product pipeline, investment analysis, a geographical operating segments analysis, and how Abbott Laboratories has been working at the forefront during the COVID-19 pandemic are all analyzed comprehensively in this report.
The major competitors of Abbott Laboratories, namely Dr. Reddy's Laboratories Limited, Johnson & Johnson, and Novartis AG, are analyzed through a company profile, in-depth business segment analysis, a financial analysis, and SWOT analysis. An economic analysis of Abbott Laboratories is also presented through ratio analysis, profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of Abbott Laboratories completes this in-depth company analysis.
Table of Contents
A. Executive SummaryH. Abbott Laboratories: OutlookI. Glossary of Terms
B. Looking at the Industry
C. Looking at Abbott Laboratories
D. Looking at Business
E. SWOT Framework Analysis
F. Profiling the Competition
G. Financial Analysis of the Company
Companies Mentioned
- Abbott Laboratories
- Dr. Reddy's Laboratories Limited
- Johnson & Johnson
- Novartis AG
